205. Fragile X syndrome related disease Clinical trials / Disease details
Clinical trials : 5 / Drugs : 7 - (DrugBank : 5) / Drug target genes : 22 - Drug target pathways : 25
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02197104 (ClinicalTrials.gov) | January 2015 | 14/7/2014 | Citocoline for Treatment in Fragile X-associated Tremor/Ataxia Syndrome | Phase 2 Study of Citocoline for Treatment in Fragile X-associated Tremor/Ataxia Syndrome | Fragile X Tremor/Ataxia Syndrome | Drug: citocoline | Rush University Medical Center | NULL | Completed | 18 Years | 90 Years | All | 10 | Phase 2 | United States |